REVIEW

1. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?
2. Hepatobiliary manifestations in inflammatory bowel disease: A practical approach

MINIREVIEWS

1. Cytomegalovirus infection in liver-transplanted children
2. Hepatocellular carcinoma in patients with metabolic dysfunctionassociated fatty liver disease: Can we stratify at-risk populations?
3. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma

ORIGINAL ARTICLE

1. Development of the nervous system in mouse liver Naoto Koike, Tomomi Tadokoro, Yasuharu Ueno, Satoshi Okamoto, Tatsuya Kobayashi, Soichiro Murata,
2. Takotsubo cardiomyopathy in orthotopic liver transplant recipients:A cohort study using multi-center pooled electronic health record data
3. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis
4. Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure
5. β-arrestin-2 predicts the clinical response to β-blockers in cirrhotic portal hypertension patients: A prospective study

SYSTEMATIC REVIEWS

1. Timing of surgical repair of bile duct injuries after laparoscopic cholecystectomy: A systematic review

CASE REPORT

1. Learning from a rare phenomenon — spontaneous clearance of chronic hepatitis C virus post-liver transplant: A case report
2. Step-up approach in emphysematous hepatitis: A case report
3. Glycogen hepatopathy in type-1 diabetes mellitus: A case report

LETTER TO THE EDITOR

1. COVID-19 and liver disease: Are we missing something?